FluoroPharma Medical Announces Acceptance of Abstract from Phase II Clinical Trial of CardioPET (18F FCPHA) for Oral ...

FluoroPharma Medical, Inc. , a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography technology for the detection and assessment of disease ...



from Content Keyword RSS http://ift.tt/1s2vYM9

via IFTTT